Tumor macrophages are pivotal constructors of tumor collagenous matrix

Journal of Experimental Medicine

Volumn 213, Issue 11, 2016, Pages 2315-2331

  Afik, Ran ^a   Zigmond, Ehud ^b   Vugman, Milena ^b   Klepfish, Mordehay ^a   Shimshoni, Elee ^a   Pasmanik Chor, Metsada ^b   Shenoy, Anjana ^b   Bassat, Elad ^a   Halpern, Zamir ^b   Geiger, Tamar ^b   Sagi, Irit ^a   Varol, Chen ^b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 14; COLLAGEN TYPE 6; SCLEROPROTEIN; CCR2 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR2; FIBRILLAR COLLAGEN; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER GROWTH; CANCER MODEL; COLLAGEN FIBER; COLLAGEN SYNTHESIS; COLORECTAL CANCER; CROSS LINKING; EXTRACELLULAR MATRIX; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; TRANSCRIPTOMICS; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; C57BL MOUSE; CARCINOGENESIS; CELL PROLIFERATION; COLORECTAL TUMOR; DEFICIENCY; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MACROPHAGE; METABOLISM; PATHOLOGY; ULTRASTRUCTURE;

ANIMALS; CANCER-ASSOCIATED FIBROBLASTS; CARCINOGENESIS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBRILLAR COLLAGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MACROPHAGES; MICE, INBRED C57BL; PROTEOMICS; RECEPTORS, CCR2; TRANSCRIPTOME; TUMOR MICROENVIRONMENT;

EID: 84994608211     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20151193     Document Type: Article

References (55)

1. Bain, C.C., C.L. Scott, H. Uronen-Hansson, S. Gudjonsson, O. Jansson, O. Grip, M. Guilliams, B. Malissen, W.W. Agace, and A.M. Mowat. 2013. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol. 6:498-510. http://dx.doi.org/10.1038/mi.2012.89.
2. Bain, C.C., A. Bravo-Blas, C.L. Scott, E. Gomez Perdiguero, F. Geissmann, S. Henri, B. Malissen, L.C. Osborne, D. Artis, and A.M. Mowat. 2014. Constant replenishment from circulating monocytes maintains the macrophage pool in the intestine of adult mice. Nat. Immunol. 15:929-937. http://dx.doi.org/10.1038/ni.2967.
3. Biswas, S.K., P. Allavena, and A. Mantovani. 2013. Tumor-associated macrophages: functional diversity, clinical significance, and open questions. Semin. Immunopathol. 35:585-600. http://dx.doi.org/10.1007./s00281-013-0367-7.
4. Bogunovic, M., F. Ginhoux, J. Helft, L. Shang, D. Hashimoto, M. Greter, K. Liu, C. Jakubzick, M.A. Ingersoll, M. Leboeuf, et al. 2009. Origin of the lamina propria dendritic cell network. Immunity. 31:513-525. http://dx.doi.org/10.1016/j.immuni.2009.08.010.
5. Collighan, R.J., and M. Griffin. 2009. Transglutaminase 2 cross-linking of matrix proteins: biological significance and medical applications. Amino Acids. 36:659-670. http://dx.doi.org/10.1007/s00726-008-0190-y
6. Coussens, L.M., L. Zitvogel, and A.K. Palucka. 2013. Neutralizing tumorpromoting chronic inflammation: a magic bullet? Science. 339:286-291. http://dx.doi.org/10.1126/science.1232227.
7. Cox, J., N. Neuhauser, A. Michalski, R.A. Scheltema, J.V. Olsen, and M. Mann. 2011. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10:1794-1805. http://dx.doi.org/10.1021/pr101065j
8. Erez, N., M. Truitt, P. Olson, S.T. Arron, and D. Hanahan. 2010. Cancerassociated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-κB-dependent manner. Cancer Cell. 17:135-147. http://dx.doi.org/10.1016/j.ccr.2009.12.041.
9. Franklin, R.A., W. Liao, A. Sarkar, M.V. Kim, M.R. Bivona, K. Liu, E.G. Pamer, and M.O. Li. 2014. The cellular and molecular origin of tumorassociated macrophages. Science. 344:921-925. http://dx.doi.org/10.1126/science.1252510.
10. Gerecke, D.R., X. Meng, B. Liu, and D.E. Birk. 2003. Complete primary structure and genomic organization of the mouse Col14a1 gene. Matrix Biol. 22:209-216. http://dx.doi.org/10.1016/S0945-053X(03)00021-0.
11. Gilkes, D.M., G.L. Semenza, and D. Wirtz. 2014. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat. Rev. Cancer. 14:430-439. http://dx.doi.org/10.1038/nrc3726.
12. Huang, W., B.T. Sherman, and R.A. Lempicki. 2009. Systematic and integrative analysis of large gene lists using DAV ID bioinformatics resources. Nat. Protoc. 4:44-57. http://dx.doi.org/10.1038/nprot.2008.211.
13. Jung, S., J. Aliberti, P. Graemmel, M.J. Sunshine, G.W. Kreutzberg, A. Sher, and D.R. Littman. 2000. Analysis of fractalkine receptor CX(3)CR1. function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell. Biol. 20:4106-4114. http://dx.doi.org/10.1128/MCB.20.11.4106-4114.2000.
14. Kalluri, R., and M. Zeisberg. 2006. Fibroblasts in cancer. Nat. Rev. Cancer. 6:392-401. http://dx.doi.org/10.1038/nrc1877.
15. Kessenbrock, K., V. Plaks, and Z. Werb. 2010. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 141:52-67. http://dx.doi.org/10.1016/j.cell.2010.03.015.
16. Knipper, J.A., S. Willenborg, J. Brinckmann, W. Bloch, T. Maaß, R. Wagener, T. Krieg, T. Sutherland, A. Munitz, M.E. Rothenberg, et al. 2015. Interleukin-4 receptor a signaling in myeloid cells controls collagen fibril assembly in skin repair. Immunity. 43:803-816. http://dx.doi.org/10.1016/j.immuni.2015.09.005.
17. Levental, K.R., H. Yu, L. Kass, J.N. Lakins, M. Egeblad, J.T. Erler, S.F. Fong, K. Csiszar, A. Giaccia, W. Weninger, et al. 2009. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell. 139:891-906. http://dx.doi.org/10.1016/j.cell.2009.10.027.
18. Liguori, M., G. Solinas, G. Germano, A. Mantovani, and P. Allavena. 2011. Tumor-associated macrophages as incessant builders and destroyers of the cancer stroma. Cancers (Basel). 3:3740-3761. http://dx.doi.org/10.3390/cancers3043740.
19. Lin, E.Y., and J.W. Pollard. 2007. Tumor-associated macrophages press the angiogenic switch in breast cancer. Cancer Res. 67:5064-5066. http://dx.doi.org/10.1158/0008-5472.CAN-07-0912.
20. Lin, E.Y., A.V. Nguyen, R.G. Russell, and J.W. Pollard. 2001. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193:727-740. http://dx.doi.org/10.1084/jem.193.6.727.
21. Lu, P., V.M. Weaver, and Z. Werb. 2012. The extracellular matrix: a dynamic niche in cancer progression. J. Cell Biol. 196:395-406. http://dx.doi.org/10.1083/jcb.201102147.
22. Martinez, F.O., L. Helming, R. Milde, A. Varin, B.N. Melgert, C. Draijer, B. Thomas, M. Fabbri, A. Crawshaw, L.P. Ho, et al. 2013. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. Blood. 121:e57-e69. http://dx.doi.org/10.1182/blood-2012-06-436212.
23. Mason, S.D., and J.A. Joyce. 2011. Proteolytic networks in cancer. Trends Cell Biol. 21:228-237. http://dx.doi.org/10.1016/j.tcb.2010.12.002.
24. Mehta, K., A. Kumar, and H.I. Kim. 2010. Transglutaminase 2: a multi-tasking protein in the complex circuitry of inflammation and cancer. Biochem. Pharmacol. 80:1921-1929. http://dx.doi.org/10.1016/j.bcp.2010.06.029.
25. Mohamed, M.M., and B.F. Sloane. 2006. Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer. 6:764-775. http://dx.doi.org/10.1038/nrc1949.
26. Movahedi, K., D. Laoui, C. Gysemans, M. Baeten, G. Stangé, J. Van den Bossche, M. Mack, D. Pipeleers, P. In't Veld, P. De Baetselier, and J.A. Van Ginderachter. 2010. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 70:5728-5739. http://dx.doi.org/10.1158/0008.-5472.CAN-09-4672.
27. Murphy, G. 2008. The ADAMs: signalling scissors in the tumour microenvironment. Nat. Rev. Cancer. 8:932-941. http://dx.doi.org/10.1038/nrc2459.
28. Murray, P.J., J.E. Allen, S.K. Biswas, E.A. Fisher, D.W. Gilroy, S. Goerdt, S. Gordon, J.A. Hamilton, L.B. Ivashkiv, T. Lawrence, et al. 2014. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 41:14-20. http://dx.doi.org/10.1016/j.immuni.2014.06.008.
29. Naba, A., K.R. Clauser, S. Hoersch, H. Liu, S.A. Carr, and R.O. Hynes. 2012. The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices. Mol. Cell. Proteomics. 11:M111.014647. http://dx.doi.org/10.1074/mcp.M111.014647.
30. Naba, A., K.R. Clauser, C.A. Whittaker, S.A. Carr, K.K. Tanabe, and R.O. Hynes. 2014. Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver. BMC Cancer. 14:518. http://dx.doi.org/10.1186/1471-2407-14-518.
31. Naba, A., K.R. Clauser, H. Ding, C.A. Whittaker, S.A. Carr, and R.O. Hynes. 2016. The extracellular matrix: Tools and insights for the "omics" era. Matrix Biol. 49:10-24. http://dx.doi.org/10.1016/j.matbio.2015.06.003.
32. Nebuloni, M., L. Albarello, A. Andolfo, C. Magagnotti, L. Genovese, I. Locatelli, G. Tonon, E. Longhi, P. Zerbi, R. Allevi, et al. 2016. Insight on colorectal carcinoma infiltration by studying perilesional extracellular matrix. Sci. Rep. 6:22522. http://dx.doi.org/10.1038/srep22522.
33. Nikolic-Paterson, D.J., S. Wang, and H.Y. Lan. 2014. Macrophages promote renal fibrosis through direct and indirect mechanisms. Kidney Int Suppl (2011). 4:34-38. http://dx.doi.org/10.1038/kisup.2014.7.
34. Noy, R., and J.W. Pollard. 2014. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 41:49-61. http://dx.doi.org/10.1016./j.immuni.2014.06.010.
35. Park, J., and P.E. Scherer. 2012. Adipocyte-derived endotrophin promotes malignant tumor progression. J. Clin. Invest. 122:4243-4256. http://dx.doi.org/10.1172/JCI63930.
36. Perryman, L., and J.T. Erler. 2014. Lysyl oxidase in cancer research. Future Oncol. 10:1709-1717. http://dx.doi.org/10.2217/fon.14.39.
37. Pickup, M.W., J.K. Mouw, and V.M. Weaver. 2014. The extracellular matrix modulates the hallmarks of cancer. EMBO Rep. 15:1243-1253. http://dx.doi.org/10.15252/embr.201439246.
38. Provenzano, P.P., K.W. Eliceiri, J.M. Campbell, D.R. Inman, J.G. White, and P.J. Keely. 2006. Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med. 4:38. http://dx.doi.org/10.1186./1741-7015-4-38.
39. Provenzano, P.P., D.R. Inman, K.W. Eliceiri, J.G. Knittel, L. Yan, C.T. Rueden, J.G. White, and P.J. Keely. 2008. Collagen density promotes mammary tumor initiation and progression. BMC Med. 6:11. http://dx.doi.org/10.1186/1741-7015-6-11.
40. Qian, B.Z., J. Li, H. Zhang, T. Kitamura, J. Zhang, L.R. Campion, E.A. Kaiser, L.A. Snyder, and J.W. Pollard. 2011. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature. 475:222-225. http://dx.doi.org/10.1038/nature10138.
41. Sangaletti, S., E. Di Carlo, S. Gariboldi, S. Miotti, B. Cappetti, M. Parenza, C. Rumio, R.A. Brekken, C. Chiodoni, and M.P. Colombo. 2008. Macrophage-derived SPA RC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer Res. 68:9050-9059. http://dx.doi.org/10.1158/0008-5472.CAN-08-1327.
42. Schnoor, M., P. Cullen, J. Lorkowski, K. Stolle, H. Robenek, D. Troyer, J. Rauterberg, and S. Lorkowski. 2008. Production of type VI collagen by human macrophages: a new dimension in macrophage functional heterogeneity. J. Immunol. 180:5707-5719. http://dx.doi.org/10.4049/jimmunol.180.8.5707.
43. Schönherr, E., P. Witsch-Prehm, B. Harrach, H. Robenek, J. Rauterberg, and H. Kresse. 1995. Interaction of biglycan with type I collagen. J. Biol. Chem. 270:2776-2783. http://dx.doi.org/10.1074/jbc.270.6.2776.
44. Shand, F.H., S. Ueha, M. Otsuji, S.S. Koid, S. Shichino, T. Tsukui, M. Kosugi-Kanaya, J. Abe, M. Tomura, J. Ziogas, and K. Matsushima. 2014. Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes. Proc. Natl. Acad. Sci. USA. 111:7771-7776. http://dx.doi.org/10.1073/pnas.1402914111.
45. Sharon, Y., L. Alon, S. Glanz, C. Servais, and N. Erez. 2013. Isolation of normal and cancer-associated fibroblasts from fresh tissues by fluorescence activated cell sorting (FACS). J. Vis. Exp. e4425. http://dx.doi.org/10.3791/4425.
46. Varol, C., L. Landsman, D.K. Fogg, L. Greenshtein, B. Gildor, R. Margalit, V. Kalchenko, F. Geissmann, and S. Jung. 2007. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J. Exp. Med. 204:171-180. http://dx.doi.org/10.1084/jem.20061011.
47. Varol, C., A. Vallon-Eberhard, E. Elinav, T. Aychek, Y. Shapira, H. Luche, H.J. Fehling, W.D. Hardt, G. Shakhar, and S. Jung. 2009. Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity. 31:502-512. http://dx.doi.org/10.1016/j.immuni.2009.06.025.
48. Varol, C., A. Mildner, and S. Jung. 2015. Macrophages: development and tissue specialization. Annu. Rev. Immunol. 33:643-675. http://dx.doi.org/10.1146/annurev-immunol-032414-112220.
49. Wang, S., X.M. Meng, Y.Y. Ng, F.Y. Ma, S. Zhou, Y. Zhang, C. Yang, X.R. Huang, J. Xiao, Y.Y. Wang, et al. 2016. TGF-β/Smad3 signalling regulates the transition of bone marrow-derived macrophages into myofibroblasts during tissue fibrosis. Oncotarget. 7:8809-8822. http://dx.doi.org/10.18632/oncotarget.6604.
50. Wyckoff, J.B., Y. Wang, E.Y. Lin, J.F. Li, S. Goswami, E.R. Stanley, J.E. Segall, J.W. Pollard, and J. Condeelis. 2007. Direct visualization of macrophageassisted tumor cell intravasation in mammary tumors. Cancer Res. 67:2649-2656. http://dx.doi.org/10.1158/0008-5472.CAN-06-1823.
51. Xue, J., S.V. Schmidt, J. Sander, A. Draffehn, W. Krebs, I. Quester, D. De Nardo, T.D. Gohel, M. Emde, L. Schmidleithner, et al. 2014. Transcriptomebased network analysis reveals a spectrum model of human macrophage activation. Immunity. 40:274-288. http://dx.doi.org/10.1016/j.immuni.2014.01.006.
52. Zheng, Q., and X.J. Wang. 2008. GOE AST: a web-based software toolkit for Gene Ontology enrichment analysis. Nucleic Acids Res. 36:W358-W363. http://dx.doi.org/10.1093/nar/gkn276.
53. Zigmond, E., Z. Halpern, E. Elinav, E. Brazowski, S. Jung, and C. Varol. 2011. Utilization of murine colonoscopy for orthotopic implantation of colorectal cancer. PLoS One. 6:e28858. http://dx.doi.org/10.1371/journal.pone.0028858.
54. Zigmond, E., C. Varol, J. Farache, E. Elmaliah, A.T. Satpathy, G. Friedlander, M. Mack, N. Shpigel, I.G. Boneca, K.M. Murphy, et al. 2012. Ly6Chi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity. 37:1076-1090. http://dx.doi.org/10.1016/j.immuni.2012.08.026.
55. Zigmond, E., B. Bernshtein, G. Friedlander, C.R. Walker, S. Yona, K.W. Kim, O. Brenner, R. Krauthgamer, C. Varol, W. Müller, and S. Jung. 2014. Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10. deficiency, causes severe spontaneous colitis. Immunity. 40:720-733. http://dx.doi.org/10.1016/j.immuni.2014.03.012.